Amid overwhelming public demand for alternative COVID-19 vaccines, IHH Singapore officially began offering its first batch of 10,000 doses of the Sinopharm COVID-19 vaccine on 30 August.
With this first batch of 10,000 doses offered across Gleneagles Hospital, Mount Elizabeth Hospital and Parkway Shenton clinics in Duxton and One Raffles Quay, IHH Singapore is able to inoculate some 5,000 people.
Dr Noel Yeo, Chief Operating Officer of IHH Healthcare Singapore, said that more than 6,000 individuals had registered their interest to receive the Sinopharm vaccine even before it was made available.
"We were aware there is a demand for alternative vaccines. However, the response for Sinopharm has been overwhelming. We are making plans for second orders but we have to clear approvals from HSA (Health Sciences Authority) first,” he said.
For those looking for alternative vaccines, the Sinopharm vaccine has a reported higher efficacy rate compared to the Sinovac vaccine - 79 per cent compared to 51 per cent - and reportedly milder side effects.
Related Stories
Fortis Healthcare Expands Footprint with New 200-Bed Hospital in Greater Noida
See how Fortis strengthens its Delhi-NCR network and enhances access to quality care.
Fortis Manesar Breaks New Ground in Cardiac Care
Discover how a life-changing, minimally invasive procedure gave a 16-year-old patient a second chance
IHH Healthcare Debuts FutureHealth.Now Conference
See how we united visionary minds across healthcare, government and business to spark bold ideas and forge new partnerships that will push the boundaries of care at our inaugural global leadership conference.
Unveiling Our New IHH Healthcare Identity
Prince Court Medical Centre Performs Malaysia’s First Kelly Procedure
